ONC
BeOne MedicinesBNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-22
Current thesis
Composite grade B from latest DB weights. Momentum 58.5 / Value 59.4
Posture
Constructive
Lead driver
Value
What changed
Value remains the lead driver in the composite, 7D delta -0.1.
What can break
Mixed signals. Wait for cleaner trend confirmation.
Momentum
58
Value
59
Sentiment
N/A
Setup hits (3d)
0 · Net Neutral
AI TargetsBase - · Bull - · Bear -
Data freshness
Prices
As of 2026-07-22
Fundamentals
As of 2026-07-21 • Vendor: Data Vendor v1
Scores
As of 2026-07-22 • Model: HYBRID_IC_RP
AI Memo
Unavailable: No memo yet
Investment thesisAs of 2026-07-22
Investment thesis
As of 2026-07-22
Supporting evidence
What
Grade B · Constructive
Confidence Medium · Net Neutral
Target $415.45
Why
Momentum58 · Δ7d +26.1
Value59 · Δ7d -0.1
SentimentN/A · Δ7d -
So what
Strength-led posture (Net Neutral). Favor watchlist adds and disciplined entries.
Lead driver: Value · See fundamentals
Momentum
58
40% active weight
Current posture
7d trendImproving
Δ7d
+26.1
Δ21d
+30.4
Value
59
60% active weight
Current posture
7d trendFlat
Δ7d
-0.1
Δ21d
-0.4
Sentiment
N/A
Coverage pending
No current score
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Why this grade
Composite grade B. Momentum 58.5 / Value 59.4
Fundamentals (TTM)As of 2026-07-21
Fundamentals (TTM)
As of 2026-07-21
Market Cap
$37.44B
Beta
0.52
Shares Out
102.3M
P/E (TTM)
615.3
P/S (TTM)
8.15
P/FCF (TTM)
87.32
Rev YoY
+35.7%
EPS YoY
+17028.7%
Gross Margin
+86.2%
Op Margin
+2.2%
Net Debt
-$2.59B
Current Ratio
3.64
As of 2026-07-22 • Updated nightlySource: Internal modelMethodology